Fixed Income Commentary: As at June 30, 2023

Published: July 19, 2023
Author: Phil Mesman, CFA

Equities have generally benefited from disinflation and a pause of the rate hike by the U.S. Federal Reserve (“Fed Pause”) in Q2 2023. Inflation is falling and the economy is moderating. This has had a positive impact on equities, with valuations expanding. Growth sectors have been particularly strong, likely due to a combination of discounted cash-flow valuations that are more sensitive to changes in inflation and the bursting of generative artificial intelligence (AI) onto the global scene.

Holdings that contributed to absolute performance:

NVIDIA Corporation (NVIDIA)

At the end of May, Nvidia reported a quarter that announced that the AI moment had arrived.The company guided to a blowout Q2 with revenues that were 60% ahead of expectations.Revenues are expected to increase 65% year-over-year and 53% on a quarter-over-quarter basis.Enthusiasm for Large Language Models is propelling Nvidia’s data centre business.The company also commented that the data centre business in the second half of the year would be meaningfully higher than the first half which is a sign of confidence that the July guidance is actually a production constrained forecast.

Eli Lilly and Company (Eli Lilly)

An impressive string of events for Eli Lilly vaulted it past Johnson & Johnson (JNJ) in terms of market capitalization during the quarter.Towards the end of April, the company reported impressive quarterly results where its key drug, Mounjaro, beat street estimates by over $100M allowing the company to raise their 2023 outlook.Simultaneously, the company released impressive top line data for the Mounjaro Surmout-2 Phase 3 obesity trial which enables Eli Lilly to file for an expanded indication for the drug.Then, in May, Eli Lilly showed promising Phase 3 results in Alzheimer patients and Alz readouts opening up another $20B market opportunity. Finally, towards quarter end, Eli Lilly’s obesity pill demonstrated low teens percentage weight loss at 36 weeks and had not yet plateaued, which suggests the possibility of additional weight loss with longer treatment.

Holdings that detracted from absolute performance:

Progressive Corporation. (Progressive)

Progressive shares came under pressure following its March monthly report which showed its second worst monthly loss ratio in 23 years.Most notably, the personal auto segment reported a combined ratio of 104.5% including an 84.2% reported loss ratio – well in excess of estimates of around 92% and 73% respectively.Our belief is that this was a one-time aberration that was driven by new Florida tort reform.The reform, which took effect towards the end of March aims to address concerns over the litigious nature of the state.Among the changes was the lowering of the statute of limitations to two years from four.This resulted in a flurry of lawsuits/claims being filed in the week leading up to the reform taking place.

Estee Lauder Inc. (EL)

In early May, Estee Lauder reported a very disappointing quarter resulting in them cutting their full year guidance.EPS was cut 45% below its initial guidance.The culprit appears to have been EL’s significant reliance on Asian travel retail where inventories were excessively high.EL massively overestimated near-term growth prospects in Hainan.Through most of the pandemic, Chinese consumers couldn’t leave the country but Hainan was accessible and a frequent shopping destination.This meant longer visits for Chinese consumers and higher transactions for EL in a jurisdiction where EL had outsized market share.The company therefore ended up wrong footed when travel restrictions loosened and the Chinese started migrating travel patterns to Japan, a country where EL under-indexes.

Small Cap Spotlight

We would like to highlight our position in (KSI) – offers a software platform that is used for electronic validation processes primarily in the life sciences sector. The company boasts 8 of the top 10 global pharmaceutical companies as customers which positions it as the global leader in its niche vertical. Growth within its current customer base (expanding use across more global locations + adding more processes), new logo customer growth, as well as customer wins in new verticals (consumer packaged goods companies) leaves Kneat with a long runway of growth. In addition, having displayed the benefits of their core data validation software platform, Kneat has been expanding its total addressable market (TAM) by adding new quality assurance processes which adds another leg of long-term growth to the company. They have had strong momentum recently in new customer wins as well as progress in being deployed across existing customers, which has led to Annual Recurring Revenue (ARR) growth of ~85% in the most recent quarter. Given their very strong competitive positioning, high quality customer base and high growth profile we believe there is an attractive risk/reward.

Outlook and Opportunities

Overall, we believe we continue to remain within the eye of the hurricane at a macroeconomic level but have received an albeit short-term boost from the clearing of the US debt ceiling this quarter.

We also recognize that AI related momentum and a broader “fear of missing out” for those who moved into cash instruments may continue to elevate the current market run in the short-term.

On the more medium term we remain concerned on the growing probability of a hard landing given where the ISM Services PMI and other factors are trending.

With respect to positioning we continue to be selective in our positioning – adding to names that exhibit structural growth and who trade at reasonable valuations.

Our belief is that those who can provide growth will be rewarded in the next cycle.

Thematically, we are positive and long term bullish on housing (i.e. homebuilders, building material distributors, and property managers) as a whole given the extreme supply/demand imbalance on both sides of the border.

Furthermore, we also remain positive in the long-run on commodities (i.e. copper) and materials but have a more muted to neutral position at the moment given where we are in the current cycle.

Related Content

Equity Commentary: As at March 31, 2024

Equity Commentary: As at March 31, 2024

The rise in equity prices has certainly been impressive. U.S. equity markets ended the first quarter of 2024 at all-time highs despite two of the MAG 7 stocks being negative year to date –...

This material has been published by Picton Mahoney Asset Management (“PMAM”) on July 19, 2023

It is provided as a general source of information, is subject to change without notification and should not be construed as investment advice. This material should not be relied upon for any investment decision and is not a recommendation, solicitation or offering of any security in any jurisdiction. The information contained in this material has been obtained from sources believed reliable, however, the accuracy and/or completeness of the information is not guaranteed by PMAM, nor does PMAM assume any responsibility or liability whatsoever. All investments involve risk and may lose value. This information is not intended to provide financial, investment, tax, legal or accounting advice specific to any person, and should not be relied upon in that regard. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional.

This material may contain “forward-looking information” that is not purely historical in nature. These forward-looking statements are based upon the reasonable beliefs of PMAM as of the date they are made. PMAM assumes no duty, and does not undertake, to update any forward-looking statement. Forward-looking statements are not guarantees of future performance, are subject to numerous assumptions and involve inherent risks and uncertainties about general economic factors which change over time. There is no guarantee that any forward-looking statements will come to pass. We caution you not to place undue reliance on these statements, as a number of important factors could cause actual events or results to differ materially from those expressed or implied in any forward-looking statement made.

Commissions, trailing commissions, management fees, performance fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any unitholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. Alternative mutual funds can only be purchased through a registered dealer and are available only in those jurisdictions where they may be lawfully offered for sale.

There is no guarantee that a hedging strategy will be effective or achieve its intended effect. The use of derivatives or short selling carries several risks which may restrict a strategy in realizing its profits, limiting its losses, or, which cause a strategy to realize or magnify losses. There may additional costs and expenses associated with the use of derivatives and short selling in a hedging strategy.

This material is confidential and is intended for use by accredited investors or permitted clients in Canada only. Any review, re-transmission, dissemination or other use of this information by persons or entities other than the intended recipient is prohibited.

© 2024 Picton Mahoney Asset Management. All rights reserved.